|
⚲
|
| Keyboard |
| Inhibikase Therapeutics Inc | |
|---|---|
| Ticker | IKT |
| CIK # | 0001750149 |
| CUSIP | 45719W106 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 3350 Riverwood Parkway Se, Suite 1900, Atlanta, GA 30339 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Inhibikase Therapeutics Inc | 2024-06-04 | Exemption: 506(b) · Remaining: $7,999,999 · Duration: One year or less · Commission: $339,994 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001750149] | 10-K | |
| [0001750149] | 10-Q | |
| [0001750149] | 3 | |
| [0001750149] | 4 | |
| [0001750149] | 8-K | |
| [0001750149] | D | |
| [0001750149] | SC 13D | |
| [0001750149] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aurentz Vincent
Common Stock
|
2026-02-21 | Disposed to issuer | 255,299 | $0.00 | |
|
Munshi Amit
Common Stock
|
2026-02-21 | Disposed to issuer | 19,089 | $0.00 | |
|
Cabell Christopher
Common Stock
|
2026-02-21 | Disposed to issuer | 338,282 | $0.00 | |
|
Iwicki Mark T
Stock Option (Right to Buy) · derivative
|
2026-01-05 | Grant | 4,982,706 | $0.00 | |
|
McIntyre David
Stock Option (Right to Buy) · derivative
|
2026-01-05 | Grant | 986,319 | $0.00 | |
|
Cabell Christopher
Stock Option (Right to Buy) · derivative
|
2026-01-05 | Grant | 900,117 | $0.00 | |
|
Sands Capital Life Sciences Pulse Fund II LP +2
Common Stock
|
2025-11-21 | Buy | 2,068,965 | $1.45 | 2,999,999 |
|
Munshi Amit
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 108,176 | $0.00 | |
|
Canner David
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 108,176 | $0.00 | |
|
Aurentz Vincent
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 108,176 | $0.00 | |
|
Kush Arvind
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 108,176 | $0.00 | |
|
Bellini Roberto
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 108,176 | $0.00 | |
|
Berman Dennis N
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 108,176 | $0.00 | |
|
McIntyre David
Stock Option (Right to Buy) · derivative
|
2025-04-14 | Grant | 1,775,539 | $0.00 | |
|
Cabell Christopher
Stock Option (Right to Buy) · derivative
|
2025-02-21 | Grant | 1,100,705 | $0.00 | |
|
Iwicki Mark T
Stock Option (Right to Buy) · derivative
|
2025-02-21 | Grant | 602,346 | $0.00 | |
|
Common Stock
|
2025-02-21 | Grant | 57,265 | $0.00 | |
|
Stock Option (Right to Buy) · derivative
|
2025-02-21 | Grant | 1,100,705 | $0.00 | |
|
Stock Option (Right to Buy) · derivative
|
2025-02-21 | Grant | 602,346 | $0.00 | |
|
Stock Option (Right to Buy) · derivative
|
2025-02-21 | Grant | 134,427 | $0.00 | |
| showing 20 of 152 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 104 | 117,816,841 |
| 2025-12-31 | 74 | 106,415,335 |
| 2025-09-30 | 54 | 55,014,727 |
| 2025-06-30 | 49 | 54,516,967 |
| 2025-03-31 | 48 | 51,462,756 |
| 2024-12-31 | 32 | 50,027,780 |
| 2024-09-30 | 12 | 860,232 |
| 2024-06-30 | 13 | 836,496 |
| 2024-03-31 | 13 | 208,892 |
| 2023-12-31 | 12 | 236,671 |
| 2023-09-30 | 13 | 412,996 |
| 2023-06-30 | 15 | 760,940 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Wealth Enhancement Advisory Services LLC | [2026-06-30] | SOLE | 325 | 18,759 |
| True Wealth Design LLC | [2026-06-30] | SOLE | 0 | 499 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 370 |
| IFP Advisors LLC | [2026-06-30] | SOLE | 23 | 23 | Prev | Page 1 | Next |